BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32945790)

  • 1. The Role of Nursing in Preventing HPV-Related Cancers.
    Baldwin CM
    Clin J Oncol Nurs; 2020 Oct; 24(5):471. PubMed ID: 32945790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
    Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
    JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten Years of Human Papillomavirus Vaccination in the United States.
    Markowitz LE; Gee J; Chesson H; Stokley S
    Acad Pediatr; 2018 Mar; 18(2S):S3-S10. PubMed ID: 29502635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 12. Should men be exempted from vaccination against human papillomavirus? Health disparities regarding HPV: the example of sexual minorities in Poland.
    Reszka K; Moskal Ł; Remiorz A; Walas A; Szewczyk K; Staszek-Szewczyk U
    J Prev Med Hyg; 2021 Jun; 62(2):E386-E391. PubMed ID: 34604578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence in Germany attributable to human papillomavirus in 2013.
    Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K
    BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and Screening of HPV Malignancies.
    Dahlstrom KR; Day AT; Sturgis EM
    Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic burden of HPV-related cancers in the US veteran population.
    Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
    J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus: optimizing opportunities for prevention.
    Browne S; Feemster KA
    Curr Opin Pediatr; 2022 Apr; 34(2):132-139. PubMed ID: 35152231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human Papillomavirus: screening of cervical and anal cancers].
    Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
    Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.